Eli Lilly and Co
featured
Some of the names on the move ahead of the open.
» Read More
More
-
Baxter International Inc. rose $1.09 or 1.5 percent, to $72.94. Bristol-Myers Squibb Co. rose$. 53 or 1.2 percent, to $43.30. Hospira rose$. 02 or. 1 percent, to $35.74.
-
Baxter International Inc. rose$. 68 or. 9 percent, to $72.53. Bristol-Myers Squibb Co. rose$. 19 or. 4 percent, to $42.96. Hospira rose$. 06 or. 2 percent, to $35.78.
-
Baxter International Inc. rose$. 99 or 1.4 percent, to $72.84. Bristol-Myers Squibb Co. rose$. 28 or. 7 percent, to $43.05. Hospira rose$. 28 or. 8 percent, to $36.00.
-
Baxter International Inc. rose $1.30 or 1.8 percent, to $71.85. Bristol-Myers Squibb Co. fell $1.57 or 3.5 percent, to $42.77. Hospira rose $1.29 or 3.7 percent, to $35.72.
-
Baxter International Inc. rose$. 82 or 1.2 percent, to $71.37. Bristol-Myers Squibb Co. fell $1.64 or 3.7 percent, to $42.70. Hospira rose $1.33 or 3.8 percent, to $35.76.
-
Baxter International Inc. fell$. 05 or. 1 percent, to $70.50. Bristol-Myers Squibb Co. fell$. 53 or 1.2 percent, to $43.81. Hospira rose$. 27 or. 8 percent, to $34.70.
-
Baxter International Inc. rose$. 06 or. 1 percent, to $70.55. Bristol-Myers Squibb Co. rose $2.13 or 5.0 percent, to $44.34. Hospira rose$. 18 or. 5 percent, to $34.43.
-
SAN FRANCISCO, May 15- As Amazon.com Inc seeks to transform itself into a leading provider of technology to the world's largest corporations, it is discovering that it needs help.
-
Baxter International Inc. rose$. 02 or percent, to $70.51. Bristol-Myers Squibb Co. rose $2.90 or 6.9 percent, to $45.11. Hospira rose$. 02 or. 1 percent, to $34.27.
-
Baxter International Inc. fell$. 03 or percent, to $70.46. Bristol-Myers Squibb Co. rose$. 42 or 1.0 percent, to $42.63. Hospira fell$. 04 or. 1 percent, to $34.21.
-
Baxter International Inc. rose$. 03 or percent, to $70.49. Bristol-Myers Squibb Co. rose $1.27 or 3.1 percent, to $42.21. Hospira rose$. 02 or. 1 percent, to $34.25.
-
Baxter International Inc. rose$. 39 or. 6 percent, to $70.85. Bristol-Myers Squibb Co. rose $1.03 or 2.5 percent, to $41.97. Hospira fell$. 06 or. 2 percent, to $34.17.
-
May 14- John Lechleiter, the longtime chief executive of Eli Lilly and Co, is recovering from successful surgery to repair a dilated aorta, the U.S. drugmaker said on Tuesday. Lechleiter is recovering and will be closely monitored by the medical staff over the next several days, "following his surgery on Monday, the Indianapolis company said in a statement.
-
Baxter International Inc. rose$. 33 or. 5 percent, to $70.79. Bristol-Myers Squibb Co. rose$. 63 or 1.5 percent, to $41.57. Hospira rose$. 05 or. 1 percent, to $34.28.
-
Baxter International Inc. fell$. 30 or. 4 percent, to $70.46. Bristol-Myers Squibb Co. rose$. 45 or 1.1 percent, to $40.94. Hospira fell$. 39 or 1.1 percent, to $34.23.
-
Baxter International Inc. fell$. 03 or percent, to $70.74. Bristol-Myers Squibb Co. rose$. 24 or. 6 percent, to $40.73. Hospira fell$. 19 or. 5 percent, to $34.43.
-
Baxter International Inc. fell$. 34 or. 5 percent, to $70.42. Bristol-Myers Squibb Co. rose$. 11 or. 3 percent, to $40.60. Hospira fell$. 19 or. 6 percent, to $34.43.
-
Baxter International Inc. fell$. 23 or. 3 percent, to $70.76. Bristol-Myers Squibb Co. rose$. 56 or 1.4 percent, to $40.49. Hospira rose$. 07 or. 2 percent, to $34.62.
-
Baxter International Inc. fell$. 30 or. 4 percent, to $70.69. Bristol-Myers Squibb Co. rose$. 22 or. 6 percent, to $40.15. Hospira rose$. 04 or. 1 percent, to $34.59.
-
INDIANAPOLIS-- Eli Lilly and Co. said Friday it will stop development of an experimental cancer drug after it failed in a late-stage clinical trial. The company will take a charge of about $30 million in the second quarter, but didn't make changes to its full-year guidance. Shares of Eli Lilly added 4 cents to $54.60 in afternoon trading.